Nucleus Biologics launched the Krakatoa ® K500, which the company says is the first bioreactor-scale, pod-based media and buffer manufacturing system designed to deliver sterile solutions on demand ...

Produces 35–500 liters of sterile media and buffers on demand at point-of-use, reducing cost, complexity, and lead times Pod-based, closed single-use system with integrated analytics, QR-code-driven ...

Process liquids and buffers are necessary tools for biotherapeutic manufacturing. In small-scale process development scales, these liquids are often overlooked as the focus is usually on the molecule, ...

SAN DIEGO-- (BUSINESS WIRE)-- #bioprocess -- Nucleus Biologics, a leading provider of custom cell culture solutions and manufacturing technologies for advanced therapies, today announced the launch of ...